Stay updated on Efficacy of AMONDYS 45, EXONDYS 51, VYONDYS 53 Clinical Trial
Sign up to get notified when there's something new on the Efficacy of AMONDYS 45, EXONDYS 51, VYONDYS 53 Clinical Trial page.

Latest updates to the Efficacy of AMONDYS 45, EXONDYS 51, VYONDYS 53 Clinical Trial page
- Check6 days agoChange DetectedThe Duchenne muscular dystrophy trial record is displayed with its study design, treatments, eligibility criteria, outcome measures, and completed status. A study protocol and statistical analysis plan are also listed.SummaryDifference50%

- Check13 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 while the study record continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check34 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study details and navigation with an access-denied message.SummaryDifference18%

Stay in the know with updates to Efficacy of AMONDYS 45, EXONDYS 51, VYONDYS 53 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of AMONDYS 45, EXONDYS 51, VYONDYS 53 Clinical Trial page.